Debt-to-equity of BIOGEN INC. from 31 Dec 2010 to 31 Dec 2023
- Taxonomy & unit
- ratio: x
- Description
- Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's debt by its shareholder equity.
- Summary
-
BIOGEN INC. quarterly Debt-to-equity in x history and change rate from 31 Dec 2010 to 31 Dec 2023.
- BIOGEN INC. Debt-to-equity for the quarter ending 31 Dec 2023 was 0.82x, a 17% decline year-over-year.
Debt-to-equity, Quarterly (x)
Debt-to-equity, YoY Quarterly Change (%)
BIOGEN INC. Quarterly Debt-to-equity (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2023 | 0.82x | -0.17x | -17% | 31 Dec 2023 |
| Q3 2023 | 0.83x | -0.26x | -24% | 30 Sep 2023 |
| Q2 2023 | 0.82x | -0.34x | -29% | 30 Jun 2023 |
| Q1 2023 | 0.91x | -0.28x | -23% | 31 Mar 2023 |
| Q4 2022 | 0.99x | -0.23x | -19% | 31 Dec 2022 |
| Q3 2022 | 1.08x | -0.17x | -14% | 30 Sep 2022 |
| Q2 2022 | 1.16x | -0.11x | -9% | 30 Jun 2022 |
| Q1 2022 | 1.19x | -0.09x | -7% | 31 Mar 2022 |
| Q4 2021 | 1.22x | -0.01x | -0.92% | 31 Dec 2021 |
| Q3 2021 | 1.25x | +0.09x | +7.5% | 30 Sep 2021 |
| Q2 2021 | 1.27x | +0.19x | +18% | 30 Jun 2021 |
| Q1 2021 | 1.28x | +0.25x | +24% | 31 Mar 2021 |
| Q4 2020 | 1.23x | +0.25x | +25% | 31 Dec 2020 |
| Q3 2020 | 1.17x | +0.2x | +21% | 30 Sep 2020 |
| Q2 2020 | 1.08x | +0.15x | +16% | 30 Jun 2020 |
| Q1 2020 | 1.03x | +0.11x | +13% | 31 Mar 2020 |
| Q4 2019 | 0.99x | +0.09x | +9.7% | 31 Dec 2019 |
| Q3 2019 | 0.96x | +0.08x | +8.8% | 30 Sep 2019 |
| Q2 2019 | 0.93x | +0.06x | +7.2% | 30 Jun 2019 |
| Q1 2019 | 0.91x | +0.06x | +7.3% | 31 Mar 2019 |
| Q4 2018 | 0.9x | +0.05x | +5.9% | 31 Dec 2018 |
| Q3 2018 | 0.88x | +0.03x | +3.8% | 30 Sep 2018 |
| Q2 2018 | 0.87x | +0.01x | +1.2% | 30 Jun 2018 |
| Q1 2018 | 0.85x | -0.01x | -1.1% | 31 Mar 2018 |
| Q4 2017 | 0.85x | -0.05x | -5.3% | 31 Dec 2017 |
| Q3 2017 | 0.85x | -0.09x | -9.4% | 30 Sep 2017 |
| Q2 2017 | 0.86x | -0.12x | -12% | 30 Jun 2017 |
| Q1 2017 | 0.86x | +0.05x | +5.9% | 31 Mar 2017 |
| Q4 2016 | 0.9x | +0.26x | +41% | 31 Dec 2016 |
| Q3 2016 | 0.94x | +0.47x | +100% | 30 Sep 2016 |
| Q2 2016 | 0.98x | +0.66x | +206% | 30 Jun 2016 |
| Q1 2016 | 0.81x | +0.49x | +152% | 31 Mar 2016 |
| Q4 2015 | 0.63x | +0.3x | +92% | 31 Dec 2015 |
| Q3 2015 | 0.47x | +0.13x | +37% | 30 Sep 2015 |
| Q2 2015 | 0.32x | -0.04x | -12% | 30 Jun 2015 |
| Q1 2015 | 0.32x | -0.04x | -12% | 31 Mar 2015 |
| Q4 2014 | 0.33x | -0.05x | -13% | 31 Dec 2014 |
| Q3 2014 | 0.34x | -0.05x | -14% | 30 Sep 2014 |
| Q2 2014 | 0.36x | -0.05x | -12% | 30 Jun 2014 |
| Q1 2014 | 0.37x | -0.07x | -16% | 31 Mar 2014 |
| Q4 2013 | 0.38x | -0.07x | -16% | 31 Dec 2013 |
| Q3 2013 | 0.4x | -0.04x | -9.6% | 30 Sep 2013 |
| Q2 2013 | 0.41x | -0.02x | -4.5% | 30 Jun 2013 |
| Q1 2013 | 0.44x | +0.01x | +2.8% | 31 Mar 2013 |
| Q4 2012 | 0.45x | +0.02x | +5.5% | 31 Dec 2012 |
| Q3 2012 | 0.44x | -0.01x | -1.8% | 30 Sep 2012 |
| Q2 2012 | 0.43x | -0.03x | -6.4% | 30 Jun 2012 |
| Q1 2012 | 0.42x | -0.04x | -9.1% | 31 Mar 2012 |
| Q4 2011 | 0.43x | -0.01x | -3.3% | 31 Dec 2011 |
| Q3 2011 | 0.45x | 30 Sep 2011 | ||
| Q2 2011 | 0.46x | 30 Jun 2011 | ||
| Q1 2011 | 0.47x | 31 Mar 2011 | ||
| Q4 2010 | 0.44x | 31 Dec 2010 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.